TOL-3

N/A

Report date: 2024/03/29 16:59:18

Base Information

Drug NameTOL-3
Drug Alias NameTOL-3TOL3
ClassificationBiologics > Protein drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesToleranzia AB
China Registration ClassN/A

Develop Information

Active CompaniesToleranzia AB
Inactive CompaniesN/A
Active IndicationsAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A